Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Upadacitinib Effective in PsA After TNF Inhibitor Failure

Upadacitinib is linked to effective clinical responses in patients with psoriatic arthritis who have received prior TNF inhibitor therapy.

Does Tapering TNF Inhibitors Maintain Low Disease Activity?

In patients with psoriatic arthritis and axial spondyloarthritis, a treat-to-target tapering strategy for TNF inhibitors may maintain low disease activity for up to 2 years.

FDA Approves First Oral Drug for Dermatomyositis in Adults

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune disease, in adults.

Early Step-Down Safe, Cost-Effective in Stable Candidiasis

Switching from an echinocandin to an azole within 5 days is not associated with worse outcomes in clinically stable adults with invasive candidiasis, a study shows.

How Safe Is Lifileucel After Patients Go Home?

The T-cell therapy’s inpatient toxicity is well-characterized, but the risks patients may face after hospital discharge have been unclear.

China Approves J&J Psoriasis Pill Icotyde, Says Drugmaker

China's drug regulator has approved Johnson & Johnson's oral pill ⁠for psoriasis, the company said on Thursday, intensifying competition in the ⁠world's second-largest...

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

Upadacitinib is linked to effective clinical responses in patients with psoriatic arthritis who have received prior TNF inhibitor therapy.

In patients with psoriatic arthritis and axial spondyloarthritis, a treat-to-target tapering strategy for TNF inhibitors may maintain low disease activity for up to 2 years.

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune disease, in adults.

Switching from an echinocandin to an azole within 5 days is not associated with worse outcomes in clinically stable adults with invasive candidiasis, a study shows.

The T-cell therapy’s inpatient toxicity is well-characterized, but the risks patients may face after hospital discharge have been unclear.

China's drug regulator has approved Johnson & Johnson's oral pill ⁠for psoriasis, the company said on Thursday, intensifying competition in the ⁠world's second-largest...

News All Time

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

Antihistamines Panned for Eczema

Network meta-analysis finds no meaningful benefit across the board and some harms

FDA Staff Unconvinced Drug for Melanoma Shows Benefit

Replimune's RP1 faces tough test at upcoming FDA advisory panel meeting

Fauci's Diaries Released; Cold Brew Recalled; Carly Simon's Diagnosis

Health news and commentary gathered by MedPage Today staff

What Is the 'Barbie Peptide' and Why Is It Risky?

Dermatologists weigh in on the injectable trend

Twice-Rejected Melanoma Drug Gets Love From FDA Panel

Vote at odds with FDA reviewers

Make the Diagnosis: She’s Losing Her Scalp and Eyebrow Hair. Why?

A 51-year-old woman visited her doctor for asymptomatic hair loss on her scalp and eyebrows that she first noticed approximately 5 months prior. Can you diagnose the patient?

FDA Finally OKs Twice-Rejected Melanoma Drug

Approved in combination with nivolumab for patients who progress on prior anti-PD-1 therapy

'Carrot Maxxing' Is a New Name for an Old Trend

Eating lots of carrots can change the color of the skin, but satisfaction may vary

Tanning Is Getting Hot Again. Here's What It Really Does to Your Skin.

Tanning misinformation abounds online

Pebbled Skin and Excessive Hair Growth on a 5-Year-Old's Back

Just two of the multiple symptoms that began to emerge shortly after birth

Can 'Ferritin Face' Signal Underlying Anemia? Hematologists Weigh In

Patients attribute dull skin, brittle hair, and dark under-eye circles to ferritin deficiency

JAK Inhibitor Might Be the Most Effective One Yet for Severe Alopecia

Trials suggest more hair growth with upadacitinib in teens and adults than previously seen

Flight Attendants, Pilots Have Highest Risk of Dying From Radiation-Linked Cancers

Radiation exposure is greater for people flying at high altitudes

4 Deaths Linked to Medical Device; New FDA Chief? Human-Chimp Hybrid Attempt

Health news and commentary gathered by MedPage Today staff

How Much of a Cancer Drug Is Too Much? Some Are Challenging FDA-Approved Dosages.

— Smaller doses of some drugs could save billions and prevent some of the worst side effects

Recommended News For You

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

A novel blood test may enable the early identification of common, fatal cancers.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

More People Than Previously Believed Have Schizophrenia.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

Is a $2,000 Whole-Body MRI Worth It?

Recommended Articles For You

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

Epigenetic Signatures for Multi-Cancer Screening 

Immune Escape Landscapes in Solid Tumors 

Predicting Incidental Prostate Cancer in BPH Surgery Patients 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung nodules seen in a high percentage of non-smokers

2.

Providing essential cancer care to rural communities

3.

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

4.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

5.

De-escalation Misses the Mark in Inflammatory Breast Cancer

1.

Adaptive Cell Therapies for Solid Tumors

2.

Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights

3.

The Mysterious World of Petechiae: Exploring Causes and Treatments

4.

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health 

5.

Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

3.

Thromboprophylaxis In Medical Settings- An Update

4.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot